{
    "code": "56027997",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56027997",
    "time": "2017-06-16 03:43:40",
    "許可證字號": "衛部醫器輸字第027997號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/12\/15",
    "發證日期": "104\/12\/15",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "通關簽審文件編號": "DHA05602799702",
    "中文品名": "亞培設計師B型肝炎表面抗原定性檢驗試劑組\/亞培設計師B型肝炎表面抗原定性確認檢驗試劑組",
    "英文品名": "ABBOTT ARCHITECT HBsAg Qualitative II \/ABBOTT ARCHITECT HBsAg Qualitative II Confirmatory",
    "效能": "本產品利用化學冷光微粒免疫分析法，定性測試人類血清及血漿中的B型肝炎表面抗原(HBsAg)，包括死亡後(無心跳)所採撿的樣本。本產品可用於輔助B型肝炎感染之診斷，不可用於捐血者篩檢。",
    "醫器規格": "2G22-25，2G22-30，2G22-35，2G22-01，2G22-10，2G23-25，2G23-40。",
    "劑型": "",
    "包裝": "",
    "標籤、仿單及包裝加註": "",
    "": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B4020分析特定試劑",
    "醫器主類別二": "A臨床化學及臨床毒理學",
    "醫器次類別二": "A1150校正品",
    "醫器主類別三": "A臨床化學及臨床毒理學",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "M230097000  ABBOTT IRELAND DIAGNOSTICS DIVISION",
        "製造廠廠址": "FINISKLIN BUSINESS PARK FINISKLIN, SLIGO, IRELAND",
        "製造廠公司地址": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "56027997001-105-01-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027997&Seq=001&Type=9"
        },
        {
            "title": "56027997002-105-01-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027997&Seq=001&Type=8"
        }
    ]
}